Brief: Axcella Reports Fourth Quarter And Full Year 2020 Financial Results And Provides Business Update
March 17 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA REPORTS FOURTH QUARTER AND FULL YEAR 2020
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.40
* Q4 EARNINGS PER SHARE ESTIMATE $-0.36 -- REFINITIV IBES
DATA
* INITIATION OF AXA1665 PHASE 2 CLINICAL TRIAL IN OHE
EXPECTED IN
Q2 2021
* INITIATION OF AXA1125 PHASE 2B CLINICAL TRIAL IN NASH
EXPECTED
IN Q2 2021
Source text for Eikon: ID:nBw15T9cNa
Further company coverage: AXLA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment